Best DTx - Ophthalmology Products

Ababax is an early stage company working towards the translation of scientific findings into therapeutic approaches based on digital, non-invasive sensory stimulation.

Dopavision is a therapeutic company developing a digital therapeutic for myopia. Myopia, or shortsightedness, is a condition where the visual image is focused in front of the retina, instead of on the retina itself, as it should. People with myopia have good near sight vision but poor distance vision. Dopavision is developing a digital therapeutic for myopia which can be seamlessly and invisibly integrated with the use of a smartphone. Myopia is a visual condition that affects on average every third person globally, a share that has increased rapidly during the last two decades. The goal of the Berlin-based startup is to develop a clinically validated therapy for myopia progression in children and adolescents. The technology delivers light stimulation to specific photosensitive cells on the retina which in turn modulate dopamine, a neurotransmitter that is important for the regulation of eye growth. Founded in 2017, Dopavision GmbH is supported by the German government via the “Industrie-in-Klinik” program of the BMBF (Federal Ministry of Education and Research) with the amount of € 1.4 million over three years.

Longevity Biomedical develops and acquires technologies spanning therapeutics, health monitoring, and digital health solutions. It provides longevity-related products and services designed to improve the health span of the aging population. It cultures and researches soft tissue repair, corneal transplant, ischemic stroke, and more pipelines. The company was founded in 2022 and is based in Bothell, Washington.